DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,494 filers reported holding DANAHER CORPORATION in Q1 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $127,000 | +8.5% | 385 | 0.0% | 0.01% | -10.0% |
| Q3 2021 | $117,000 | +3.5% | 385 | -8.3% | 0.01% | +11.1% |
| Q2 2021 | $113,000 | +1.8% | 420 | -15.2% | 0.01% | -10.0% |
| Q1 2021 | $111,000 | +5.7% | 495 | +4.9% | 0.01% | 0.0% |
| Q4 2020 | $105,000 | +50.0% | 472 | +44.3% | 0.01% | +42.9% |
| Q3 2020 | $70,000 | -48.1% | 327 | -57.1% | 0.01% | -56.2% |
| Q2 2020 | $135,000 | +33.7% | 763 | +5.0% | 0.02% | +6.7% |
| Q1 2020 | $101,000 | -9.8% | 727 | 0.0% | 0.02% | +15.4% |
| Q4 2019 | $112,000 | -3.4% | 727 | -9.1% | 0.01% | -7.1% |
| Q3 2019 | $116,000 | -37.6% | 800 | -38.7% | 0.01% | -39.1% |
| Q2 2019 | $186,000 | +8.1% | 1,304 | +0.1% | 0.02% | +4.5% |
| Q1 2019 | $172,000 | +28.4% | 1,303 | +0.1% | 0.02% | +10.0% |
| Q4 2018 | $134,000 | -5.0% | 1,302 | +0.1% | 0.02% | +5.3% |
| Q3 2018 | $141,000 | +78.5% | 1,301 | +62.6% | 0.02% | +72.7% |
| Q2 2018 | $79,000 | +1.3% | 800 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $78,000 | +14.7% | 800 | +9.6% | 0.01% | +10.0% |
| Q4 2017 | $68,000 | +7.9% | 730 | 0.0% | 0.01% | +11.1% |
| Q3 2017 | $63,000 | +1.6% | 730 | 0.0% | 0.01% | -10.0% |
| Q2 2017 | $62,000 | 0.0% | 730 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $62,000 | +8.8% | 730 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $57,000 | 0.0% | 730 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $57,000 | -23.0% | 730 | 0.0% | 0.01% | -28.6% |
| Q2 2016 | $74,000 | +7.2% | 730 | 0.0% | 0.01% | +16.7% |
| Q1 2016 | $69,000 | +1.5% | 730 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $68,000 | +9.7% | 730 | 0.0% | 0.01% | +9.1% |
| Q3 2015 | $62,000 | 0.0% | 730 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $62,000 | 0.0% | 730 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $62,000 | -1.6% | 730 | 0.0% | 0.01% | -26.7% |
| Q4 2014 | $63,000 | +14.5% | 730 | 0.0% | 0.02% | +15.4% |
| Q3 2014 | $55,000 | -5.2% | 730 | 0.0% | 0.01% | -7.1% |
| Q2 2014 | $58,000 | +5.5% | 730 | 0.0% | 0.01% | +7.7% |
| Q1 2014 | $55,000 | -1.8% | 730 | 0.0% | 0.01% | -7.1% |
| Q4 2013 | $56,000 | +12.0% | 730 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $50,000 | +8.7% | 730 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $46,000 | – | 730 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |